Retractable Technologies Inc (RVP) - Total Liabilities
Based on the latest financial reports, Retractable Technologies Inc (RVP) has total liabilities worth $68.26 Million USD as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore RVP shareholders equity momentum to track the company's year-over-year net asset growth rate.
Retractable Technologies Inc - Total Liabilities Trend (2000–2025)
This chart illustrates how Retractable Technologies Inc's total liabilities have evolved over time, based on quarterly financial data. See RVP cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
Retractable Technologies Inc Competitors by Total Liabilities
The table below lists competitors of Retractable Technologies Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
RHYTHM Biosciences Ltd
AU:RHY
|
Australia | AU$955.41K |
|
Wemade Max Co. Ltd
KQ:101730
|
Korea | ₩108.81 Billion |
|
Muar Ban Lee Group Bhd
KLSE:5152
|
Malaysia | RM103.00 Million |
|
Crunchfish AB
ST:CFISH
|
Sweden | Skr6.28 Million |
|
Chonbang
KO:000950
|
Korea | ₩9.17 Billion |
|
Agat Ejendomme A/S
CO:AGAT
|
Denmark | Dkr502.00 Million |
|
Holista Colltech Ltd
AU:HCT
|
Australia | AU$6.29 Million |
|
Medicenna Therapeutics Corp
TO:MDNA
|
Canada | CA$6.85 Million |
Liability Composition Analysis (2000–2025)
This chart breaks down Retractable Technologies Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Retractable Technologies Inc stock valuation.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 6.57 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | 0.27 | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.92 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.48 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Retractable Technologies Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Retractable Technologies Inc (2000–2025)
The table below shows the annual total liabilities of Retractable Technologies Inc from 2000 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | $68.26 Million | -7.20% |
| 2024-12-31 | $73.55 Million | -8.50% |
| 2023-12-31 | $80.38 Million | -22.86% |
| 2022-12-31 | $104.21 Million | -8.58% |
| 2021-12-31 | $113.98 Million | +106.90% |
| 2020-12-31 | $55.09 Million | +218.57% |
| 2019-12-31 | $17.29 Million | +54.70% |
| 2018-12-31 | $11.18 Million | +1.79% |
| 2017-12-31 | $10.98 Million | +2.91% |
| 2016-12-31 | $10.67 Million | -7.32% |
| 2015-12-31 | $11.51 Million | -37.85% |
| 2014-12-31 | $18.52 Million | -8.28% |
| 2013-12-31 | $20.20 Million | +69.68% |
| 2012-12-31 | $11.90 Million | +17.73% |
| 2011-12-31 | $10.11 Million | -29.25% |
| 2010-12-31 | $14.29 Million | -20.70% |
| 2009-12-31 | $18.02 Million | +10.33% |
| 2008-12-31 | $16.33 Million | +29.95% |
| 2007-12-31 | $12.57 Million | +13.39% |
| 2006-12-31 | $11.08 Million | +5.36% |
| 2005-12-31 | $10.52 Million | -18.00% |
| 2004-12-31 | $12.83 Million | +51.02% |
| 2003-12-31 | $8.50 Million | -20.02% |
| 2002-12-31 | $10.62 Million | -42.20% |
| 2001-12-31 | $18.38 Million | +40.09% |
| 2000-12-31 | $13.12 Million | -- |
About Retractable Technologies Inc
Retractable Technologies, Inc. designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allerg… Read more